Antimicrobial Stewardship in the Digital Age: The Role of Artificial Intelligence and Chatbots in Future Strategies
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 15 September 2024 | Viewed by 1517
Special Issue Editor
Interests: immunology of infections; infectious disease; AI
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) is a significant global health threat that demands urgent attention. Antimicrobial stewardship (AMS) is an essential strategy for combatting AMR, focusing on the responsible use of antibiotics to preserve their efficacy. With the increasing availability of digital technologies, including artificial intelligence (AI) and chatbots, there is a growing opportunity to improve AMS strategies and outcomes. This Special Issue aims to explore the role of AI and chatbots in AMS, using ChatGPT or any other AI system as a support in decision making for new AMS approaches for future strategies. As a state-of-the-art AI model, ChatGPT can provide valuable insights and perspectives on the role of AI and chatbots in AMS.
Therefore, the Special Issue will focus on the following topics:
The current state of AMS and the challenges faced in implementing effective strategies. The potential of AI and chatbots in enhancing AMS efforts, including their applications in decision making, education, and communication with patients and healthcare providers. The ethical and legal considerations of using AI and chatbots in AMS case studies and best practices of AI and chatbot implementation in AMS, including the role of ChatGPT in supporting AMS efforts.
The Special Issue is intended for healthcare professionals, researchers, and policymakers interested in the fields of AMS, AI, and chatbots. Indeed, it has the potential to contribute significantly to the growing body of research on AMS and future strategies. Including ChatGPT and AI as supports would provide a unique and valuable perspective on the role of AI and chatbots in AMS, highlighting the potential of these technologies to enhance the responsible use of antibiotics and combat AMR.
Dr. Alessandro Perrella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- AI
- ChatGpt
- AMS
- AMR
- infection
- hospital aquired infection
